🤖 A massive ChatGPT iOS update

PLUS: AI accelerates drug discovery

Good morning AI enthusiasts!

We’re back with another batch of breaking news, tools, and more.

Who’s ready to talk AI?

In today’s AI rundown:

  • 🤖 ChatGPT unleashes mobile search via Bing

  • 💊 AI accelerates drug discovery process

  • 🎨 Adobe eases AI art fears

  • 🛠️ 6 New AI tools and 3 quick hits

Read time: 3 minutes

LATEST DEVELOPMENTS

CHATGPT

Source: 9to5Mac

Big update, folks! ChatGPT now lets ChatGPT Plus users use Bing’s web search on iOS.

For $20 a month, ChatGPT Plus subscribers on iOS can now activate browsing via Bing to get answers on recent topics and events, a leap from the free version's 2021 info cap. Simply turn on Bing browsing under ‘New Features.’

Android users, your time's coming!

TOGETHER WITH CAPECHAT

How do you keep sensitive data private while prompting LLMs like GPT-4 and GPT 3.5 Turbo?

You better have an answer…

With CapeChat, you can easily de-identify sensitive data like financial, legal, and internal docs before sending them to OpenAI.

Sign up to automatically encrypt your documents and redact sensitive data.

HEALTH

Source: NVIDIA

Here's some amazing news in the world of AI and healthcare…

Insilico Medicine, a premier member of NVIDIA Inception (NVIDIA’s startup accelerator), is cutting costs and time in drug discovery using generative AI.

Their AI-led candidate, designed to treat a rare respiratory disease, is zipping into Phase 2 trials just 2.5 years after project inception—usually, a feat that takes six years, and a whopping $400M.

AI, biology, and chemistry in one power trio—game on.

ADOBE

Source: Adobe

The AI art scene has been slowed down recently due to large amounts of fear towards specific legal concerns around permissions.

Adobe has recognized this fear and is now offering to pay copyright claims for works spun by its generative AI tool, Adobe Firefly.

This forward-thinking move could be the catalyst that sparks wider commercial use of AI-generated art.

I guess you could say the art scene is about to get an AI-powered facelift.

TRENDING TOOLS

🖊️ tl;dv transcribes, summarizes, and marks key moments in meetings in 20+ languages*

🗣️ Respeecher Marketplace allows you to speak in another person's voice and preserve emotions, volumes, and emphasis

🕒 Goodmeetings shares AI-curated moments and summaries for more productive meetings

💰 AI-Powered VC Sheet gets investors tuned into your industry so you can receive funding

💬 Double enriches your leads automatically with AI

🔮 Supertools organizes 100’s of AI tools for you in one spot

QUICK HITS

China is aggressively harnessing the power of artificial intelligence, aiming to be the world's leading AI nation. China seeks to capitalize on AI in the areas of daily office work, pharmaceuticals, and meteorology, which would significantly impact production and day-to-day life.

Microsoft announced a new AI skills initiative to bridge the technical skills gap in the workforce by providing free online courses, a global grant challenge, and a teacher training toolkit.

The initiative — connected with Azure, LinkedIn, GitHub, and other Microsoft platforms — will place its technologies at the heart of AI growth.

Scientists at the Mass General Cancer Center and the Massachusetts Institute of Technology in Cambridge have developed a new AI tool named Sybil. The tool accurately predicted an individual's risk of developing lung cancer within the next year, with a success rate of 86% to 94% in one study.

SPONSOR US

🦾 Get your product in front of over 200k+ AI enthusiasts

Our newsletter is read by thousands of tech professionals, investors, engineers, managers, and business owners around the world. Learn more or get in touch today.

* This is sponsored content

THAT’S A WRAP

If you have anything interesting to share, please reach out to us by sending us a DM on Twitter: @rowancheung & @therundownai

How was today's newsletter?

Feedback helps us improve!

Login or Subscribe to participate in polls.

❤️ Rundown review of the day

Reply

or to participate.